azathioprine has been researched along with Graves Ophthalmopathy in 6 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartalena, L | 1 |
| Tanda, ML | 1 |
| Taylor, P | 1 |
| Rajendram, R | 2 |
| Hanna, S | 1 |
| Wilson, V | 1 |
| Pell, J | 2 |
| Li, C | 2 |
| Cook, A | 2 |
| Gattamaneni, R | 2 |
| Plowman, N | 2 |
| Jackson, S | 2 |
| Hills, R | 2 |
| French, R | 1 |
| Uddin, JM | 2 |
| Lee, RWJ | 2 |
| Dayan, CM | 2 |
| Taylor, PN | 1 |
| Wilson, VJ | 1 |
| Harris, N | 1 |
| Morris, OC | 1 |
| Tomlinson, M | 1 |
| Yarrow, S | 1 |
| Garrott, H | 1 |
| Herbert, HM | 1 |
| Dick, AD | 1 |
| Jain, R | 1 |
| Olver, J | 1 |
| Hurel, SJ | 1 |
| Bremner, F | 1 |
| Drummond, SR | 1 |
| Kemp, E | 1 |
| Ritchie, DM | 1 |
| Rumsey, N | 1 |
| Morris, D | 1 |
| Lane, C | 1 |
| Palaniappan, N | 1 |
| Ezra, DG | 1 |
| Potts, MJ | 1 |
| Rose, GE | 1 |
| Bunce, C | 1 |
| Zhou, X | 1 |
| Zhou, D | 1 |
| Wang, J | 1 |
| Chen, G | 1 |
| Gonzales, M | 1 |
| Fratianni, C | 1 |
| Mamillapali, C | 1 |
| Khardori, R | 1 |
| Levy, SL | 1 |
| Salvi, SM | 1 |
3 reviews available for azathioprine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Current concepts regarding Graves' orbitopathy.
Topics: Antithyroid Agents; Azathioprine; Biological Factors; Cyclosporine; Glucocorticoids; Graves Ophthalm | 2022 |
Treatment strategies for Graves' ophthalmopathy: a network meta-analysis.
Topics: Antibodies, Monoclonal, Humanized; Azathioprine; Combined Modality Therapy; Cyclosporine; Glucocorti | 2020 |
Immunotherapy in miscellaneous medical disorders Graves ophthalmopathy, asthma, and regional painful syndrome.
Topics: Allergens; Anti-Asthmatic Agents; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal, Humanized; Ant | 2012 |
2 trials available for azathioprine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.
Topics: Azathioprine; Follow-Up Studies; Graves Ophthalmopathy; Humans; Inflammation; Quality of Life; Treat | 2023 |
Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 × 2 factorial, double-blind, randomised controlled trial.
Topics: Adult; Aged; Azathioprine; Chemoradiotherapy; Double-Blind Method; Female; Graves Ophthalmopathy; Hu | 2018 |
1 other study available for azathioprine and Graves Ophthalmopathy
| Article | Year |
|---|---|
Reactivation of Darier's disease following Azathioprine treatment for thyroid eye disease.
Topics: Azathioprine; Darier Disease; Female; Graves Ophthalmopathy; Humans; Immunosuppressive Agents; Middl | 2013 |